Zobrazeno 51 - 60
of 206
pro vyhledávání: '"Jesús K. Yamamoto-Furusho"'
Publikováno v:
Inflamm Intest Dis
Inflammatory Intestinal Diseases, Vol 5, Iss 4, Pp 200-204 (2020)
Inflammatory Intestinal Diseases, Vol 5, Iss 4, Pp 200-204 (2020)
Background and Aim: Ulcerative colitis (UC) is a subtype of inflammatory bowel disease that can develop extraintestinal manifestations (EIMs) in a subgroup of patients. The aim of this work was to study the frequency and clinical factors associated w
Autor:
Nancy E. Aguilar-Olivos, Monica R. Zavala-Solares, Luis Eduardo Zamora-Nava, Jesús K. Yamamoto-Furusho, Miguel A. Valdovinos, Julio Granados, Gabriela Fonseca-Camarillo, Guido Grajales-Figueroa, Luis R. Valdovinos-Garcia
Publikováno v:
BMC Gastroenterology, Vol 21, Iss 1, Pp 1-9 (2021)
BMC Gastroenterology
BMC Gastroenterology
Background The clinical endoscopic phenotypes of gastroesophageal reflux disease (GERD) are classified as Barrett's esophagus (BE), erosive esophagitis (EE) and non-erosive gastroesophageal reflux disease (NERD). NERD is subclassified as abnormal aci
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::184f29eebe1cefe521ecdf3600a761b3
https://doi.org/10.21203/rs.3.rs-16050/v1
https://doi.org/10.21203/rs.3.rs-16050/v1
Publikováno v:
PLoS ONE
PLoS ONE, Vol 15, Iss 4, p e0231988 (2020)
PLoS ONE, Vol 15, Iss 4, p e0231988 (2020)
BackgroundUlcerative colitis (UC) is a chronic disease characterized by periods of activity and remission. The platelet, one of the main activators of neutrophils, contains Interleukin 8 (IL-8), a potent neutrophil chemo-attractant and P-selectin tha
Publikováno v:
Gastroenterology Research and Practice, Vol 2020 (2020)
Gastroenterology Research and Practice
Gastroenterology Research and Practice
Background. Currently, the treatment goal in ulcerative colitis (UC) is to achieve clinical and endoscopic remission; nevertheless, histologic remission is a potential new treatment goal since it is associated with favorable long-term clinical outcom
Publikováno v:
Canadian Journal of Gastroenterology and Hepatology, Vol 2020 (2020)
Canadian Journal of Gastroenterology & Hepatology
Canadian Journal of Gastroenterology & Hepatology
Background. Incidence of inflammatory bowel disease (IBD), which includes ulcerative colitis (UC) and Crohn’s disease (CD), is increasing worldwide; nevertheless, it is still unknown if this is the case in Mexico. Thus, the aim of this study was to
Autor:
P Arguelles-Castro, Jesús K. Yamamoto-Furusho, A Fresan-Orellana, M Garcia-Alanis, K Bozada-Gutiérrez, A Sarmiento-Aguilar
Publikováno v:
Journal of Crohn's and Colitis. 13:S198-S200
Publikováno v:
Clinical Rheumatology. 37:677-682
The most frequent extra-intestinal manifestation in ulcerative colitis (UC) around the world is joint involvement. There are no previous data in Latin America that is about this aspect of disease; hence, the aim of this study was to determine the fre
Autor:
Kenneth Kwok, Chinyu Su, Nervin Lawendy, Hans P. Gröchenig, Gauree G. Konijeti, Uma Mahadevan, Marla Dubinsky, Daniel C. Baumgart, Nicole Kulisek, Jesús K. Yamamoto-Furusho, Thomas V. Jones
Publikováno v:
American Journal of Gastroenterology. 115:S437-S438
Autor:
E.M. Toro-Monjaraz, Jesús K. Yamamoto-Furusho, J.A. Chávez-Barrera, M. de Ariño, M.S. González-Huezo, Francisco Bosques-Padilla, M. Morales-Arámbula, María del Carmen Bojórquez-Ramos, M.V. Bielsa-Fernández, Ana I. Burguete-García, Alfredo Larrosa-Haro, A. Torre, A. González-Garay, D. Bacarreza, A.T. Abreu, José María Remes-Troche, Jaime Ramírez-Mayans, M.E. Icaza-Chávez, Miguel A. Valdovinos, C. Murata, O. Gómez-Escudero, S. Heller, T. Rizo-Robles, Judith Flores-Calderón, Enrique Coss-Adame, Ramón Carmona-Sánchez, E. Montijo, Mario Pelaez-Luna, A. Consuelo-Sánchez, M.E. Urquidi-Rivera, Francisco Guarner, R. Vázquez
Publikováno v:
Revista de Gastroenterología de México (English Edition), Vol 82, Iss 2, Pp 156-178 (2017)
Introduction Probiotics are frequently prescribed in clinical practice. Their efficacy in treating gastrointestinal disorders is supported by a significant number of clinical trials. However, the correct prescription of these agents is hampered due t
Autor:
D. Bacarreza, M.S. González-Huezo, C. Murata, Miguel A. Valdovinos, M.E. Icaza-Chávez, O. Gómez-Escudero, Jesús K. Yamamoto-Furusho, A. González-Garay, José María Remes-Troche, T. Rizo-Robles, M. Morales-Arámbula, A.T. Abreu, E.M. Toro-Monjaraz, Francisco Guarner, Ana I. Burguete-García, Francisco Bosques-Padilla, R. Vázquez, S. Heller, Jaime Ramírez-Mayans, A. Torre, Judith Flores-Calderón, M.V. Bielsa-Fernández, María del Carmen Bojórquez-Ramos, Enrique Coss-Adame, Ramón Carmona-Sánchez, M. de Ariño, J.A. Chávez-Barrera, A. Consuelo-Sánchez, Alfredo Larrosa-Haro, Mario Pelaez-Luna, E. Montijo, M.E. Urquidi-Rivera
Publikováno v:
Revista de Gastroenterología de México, Vol 82, Iss 2, Pp 156-178 (2017)
Resumen Introduccion El uso de los probioticos es comun en la practica clinica. Existe un numero significativo de estudios que apoyan la eficacia de los probioticos en algunos trastornos digestivos. Sin embargo, el desconocimiento de la evidencia cie